Business Wire

MA-BRIGHTCOVE

Share
Brightcove Introduces Smart TV SDKs for Roku, Samsung, and LG Devices, Empowering Media Companies to Reach New Audiences

Brightcove (NASDAQ: BCOV), the world’s most trusted streaming technology company, today announced the launch of its new player platforms for Roku, Samsung and LG Smart TVs. The launch of the new Software Development Kits (SDKs) has unlocked advanced features within Brightcove’s industry-leading player framework, including content protection, monetization, and analytics reporting capabilities. Designed to reduce the cost and speed of high-quality app development, media companies can more effectively target the Smart TV platforms fueling media growth while delivering a consistent, engaging premium viewer experience.

“Brightcove is committed to helping media companies deliver engaging and world-class reliable streaming experiences while reducing the costs traditionally associated with launching and running an OTT service," said Scott Levine, Chief Product Officer at Brightcove. “Our comprehensive platform enables media companies to benefit from out-of-the-box functionality and deliver premium app experiences with features previously only available in bespoke custom app development - at a fraction of the cost. "

Brightcove developed the SDKs with advertising needs in mind, supporting client-side and server-side ad insertion (CSAI, SSAI) and integrating them with digital advertising partners. Brightcove’s Roku SDK also complies with the Roku Advertising Framework (RAF), facilitating the certification process for customers. Brightcove’s Smart TV SDKs improve media handling and offer sophisticated content security capabilities, including multi-format DRM support, playback rights restrictions, and HDCP Fallback, seamlessly enabling secure delivery of premium content across all platforms.

Brightcove’s industry-leading Insights solutions also come pre-integrated. These insights, driven by the usage of the Smart TV SDKs, allow media companies to optimize ad breaks, improve player performance, identify content performance trends, pinpoint the cause of streaming quality issues, and measure impacts on viewer engagement, all to inform and enrich content, monetization and distribution strategies. The Smart TV SDKs automatically collect and report the session details impacting viewer satisfaction at scale, providing a clearer picture of overall streaming service performance and ensuring better viewer experiences.

In concert with the launch of the Smart TV SDKs, Brightcove has brought together a collection of the best video app developers to deliver options for media companies looking to meet viewers wherever they are. Partners include:

  • Accedo – a global video solutions provider powering some of the world’s most impactful and engaging video-centric experiences. Accedo offers quick launch and simplified management with their Accedo One platform, or fully customizable solutions for companies looking to truly differentiate their video app experiences.
  • Applicaster – helps content owners, OTT providers, and publishers connect with their audiences and drive business performance. The company’s Zapp platform is the industry’s most innovative no/low-code app management platform designed to give businesses the control, agility, and data they need to grow.
  • Appsfactory – a paramount European digital agency boasting an illustrious 14-year history of crafting and deploying successful digital products and solutions.
  • Arx.net/SoEasyTV – an established OTT applications provider that has developed and maintains multiple tailor-made OTT applications for large Pay TV Service Providers that support all platforms and operate with different video backend platforms. SoEasyTV OTT applications are a white-label solution that provides powerful functionalities, flexibility and a common user experience across all connected devices.
  • Enveu – an end-to-end OTT technology solutions provider to build, launch, manage and grow a video streaming business across 12+ platforms, dedicated to helping media publishers and content creators.
  • Pulselive – digital partner to some of the biggest names in sports, creating and powering digital experiences that engage millions of sports fans every day via digital products, including websites, mobile applications and emerging technologies.
  • Spyrosoft BSG – Spyrosoft BSG (formerly known as Better Software Group) is revolutionizing digital media consumption by offering modern solutions tailored to the needs of content distributors such as broadcasters, media agencies, telecommunications companies and sports organizations.
  • Robosoft Technologies – a proven digital transformation partner with a track record of crafting 10+ leading OTT streaming platforms enjoyed by millions across the globe.
  • TV2Z – a global supplier of premium cloud-based OTT services that builds and launches streaming solutions across multiple devices and operators.

The Smart TV SDKs add to Brightcove’s already leading players (which currently service ​​Web, Android, Android TV, Fire TV, iOS, iPad OS, and tvOS platforms) to propel media companies to be able to meet their audiences on any device.

For more information, visit Brightcove.com.

About Brightcove Inc.

Brightcove creates the world’s most reliable, scalable, and secure streaming technology solutions to build a greater connection between companies and their audiences, no matter where they are or on which devices they consume content. In more than 60 countries, Brightcove’s intelligent video platform enables businesses to sell to customers more effectively, media leaders to stream and monetize content more reliably, and every organization to communicate with team members more powerfully. With two Technology and Engineering Emmy® Awards for innovation, uptime that consistently leads the industry, and unmatched scalability, we continuously push the boundaries of what video can do. Follow Brightcove on LinkedIn, X, Facebook, Instagram, Threads, and YouTube. Visit Brightcove.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240415787309/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Aspect Announces CEO Leadership Transition and New Independent Board7.1.2026 00:13:00 CET | Press release

Aspect, a leading provider of cloud-based workforce management solutions, has announced a leadership transition, including the appointment of Jeff Kupietzky as Interim Chief Executive Officer and the formation of a new independent Board of Directors, marking an important next chapter for the company. As part of this transition, Darryl Kelly will step down as Chief Executive Officer and transition into a Strategic Advisor role, effective January 1, 2026. Darryl led Aspect through a pivotal period of transformation, helping reposition the business, refine its vision, and reinvigorate its innovation and execution. The company and its stakeholders thank Darryl for his leadership and contributions during a period of meaningful change. With Darryl continuing as Strategic Advisor, the organization retains continuity for employees, customers, and stakeholders. “Aspect is starting a new season, building upon the strong foundation we’ve created together,” said Darryl Kelly. “This transition is a

Brenus Pharma Reports Favorable Tolerability and Clinical Signals in Early Preliminary Results of First-In-Human Study for STC-1010 in Unresectable Metastatic Stage Colorectal Cancer (MSS CRC) Patients6.1.2026 21:00:00 CET | Press release

Brenus Pharma, a clinical stage biotechnology company unlocking the immune system in vivo to fight solid tumors, announced the successful completion of the first dose levels in its ongoing first-in-human study. The multi-center, open-label trial (NCT06934538) is a phase Ia/Ib study designed to evaluate safety, tolerability and preliminary clinical activity of STC-10101 in a first line setting. It will include in vivo analysis of immune and tumor dynamics during dose escalation of treatment and cohort extension to patients with unresectable locally advanced (stage IIIC, T4b) or unresectable metastatic (stage IV) MSS2 colorectal cancer (CRC). Early findings indicate that the first dose levels have been successfully completed with good overall tolerance and no-dose-limiting toxicities observed to date. “We are pleased to report that the safety profile observed to date is good and consistent with our expectations with no DLT,” said Paul Bravetti, CEO of Brenus Pharma. “Moreover, preliminar

SPIE, the International Society for Optics and Photonics, Announces Its 2026 Fellows6.1.2026 20:35:00 CET | Press release

The Society is welcoming 40 new Fellow Members from across the globe SPIE, the international society for optics and photonics, welcomes 40 Members as new Fellows of the Society in the 2026 cohort. They join their Fellow Member colleagues in being honored for their excellent technical achievements, as well as for their substantial service to the optics and photonics community and to SPIE. Fellows are Members of the Society who have made significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, and imaging. Since the Society's inception in 1955, more than 1,800 SPIE Members have become Fellows. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106630672/en/ SPIE, the international society for optics and photonics, announces its 2026 Fellows This year’s inductees are high-profile leaders in academia, industry, and government, many of whom are particularly prominent in their support

Chemelex Adds Electric Heat Trace Group Ltd.’s SmartTrace Monitoring Platform to its Heat Tracing Portfolio6.1.2026 20:00:00 CET | Press release

Chemelex, a global leader in electric thermal and sensing solutions, today announced the successful completion of its acquisition of substantially all the assets and ongoing operations of Electric Heat Trace Group Ltd. (EHT Group), headquartered in Ontario, Canada. This strategic move marks an exciting start to the new year and reinforces Chemelex’s commitment to delivering smarter, data-driven solutions for industrial heat trace systems. EHT Group is a recognized innovator in heat trace management, offering advanced software, integrated controller solutions, wireless communication modules, and comprehensive field services. Its flagship platform, SmartTrace, is a robust solution available in both cloud-based and on-premises deployments that enables predictive maintenance, minimizes downtime, and provides secure remote monitoring—helping customers achieve greater reliability and operational efficiency. This endeavor will help Chemelex support greater operational efficiencies for our cus

ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+ Advanced GEA6.1.2026 19:30:00 CET | Press release

Combination therapy showed compelling survival and disease control compared to current standard, regardless of PD-L1 statusHigh GEA burden in Asia, where BeOne holds ZIIHERA rights, signals potential broad patient impactResults to be presented as a Late-Breaking Abstract Oral Presentation at ASCO GI on January 8, 2026 BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced full results from the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® (zanidatamab), a HER2-targeted bispecific antibody, in combination with chemotherapy, with and without PD-1 inhibitor TEVIMBRA® (tislelizumab), as a first-line treatment for HER2-positive (HER2+) locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). These data, including the first interim overall survival (OS) analysis, will be presented as a Late-Breaking Abstract Oral Presentation (#LBA285) at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) on

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye